Robert A. Bradway

Robert A. Bradway is an American businessman and the Chairman and CEO of Amgen, a leading biotechnology company focused on developing therapies for serious diseases. Under his leadership since 2012, Amgen has expanded its product line and invested in innovative research. Bradway has a background in finance and operations, having previously served in various roles within the company, including Chief Financial Officer. He holds degrees from Amherst College and the University of Chicago. His leadership style emphasizes scientific integrity and patient-centric solutions, making significant contributions to the healthcare industry.